267 related articles for article (PubMed ID: 24519603)
21. Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.
Santos M; Cintra MA; Monteiro AL; Santos B; Gusmão-Filho F; Andrade MV; Noronha K; Cruz LN; Camey S; Tura B; Kind P
Med Decis Making; 2016 Feb; 36(2):253-63. PubMed ID: 26492896
[TBL] [Abstract][Full Text] [Related]
22. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
23. Valuation of the EQ-5D-3L in Russia.
Omelyanovskiy V; Musina N; Ratushnyak S; Bezdenezhnykh T; Fediaeva V; Roudijk B; Purba FD
Qual Life Res; 2021 Jul; 30(7):1997-2007. PubMed ID: 33713323
[TBL] [Abstract][Full Text] [Related]
24. Censoring Time Trade-off Values at 0 Versus at -1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data?
Yang Z; Rand K; Luo N
Value Health; 2023 May; 26(5):685-693. PubMed ID: 36375679
[TBL] [Abstract][Full Text] [Related]
25. US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
Shaw JW; Johnson JA; Coons SJ
Med Care; 2005 Mar; 43(3):203-20. PubMed ID: 15725977
[TBL] [Abstract][Full Text] [Related]
26. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data.
Ramos-Goñi JM; Oppe M; Estévez-Carrillo A; Rivero-Arias O;
Value Health; 2022 May; 25(5):835-843. PubMed ID: 35500952
[TBL] [Abstract][Full Text] [Related]
27. Valuation of Health States Considered to Be Worse Than Death-An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies.
Gandhi M; Rand K; Luo N
Value Health; 2019 Mar; 22(3):370-376. PubMed ID: 30832976
[TBL] [Abstract][Full Text] [Related]
28. Multiplicative modelling of EQ-5D-3L TTO and VAS values.
Shafie AA; Vasan Thakumar A
Eur J Health Econ; 2020 Dec; 21(9):1411-1420. PubMed ID: 32892230
[TBL] [Abstract][Full Text] [Related]
29. Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states.
Lipman SA; Reckers-Droog VT; Karimi M; Jakubczyk M; Attema AE
Eur J Health Econ; 2021 Dec; 22(9):1507-1518. PubMed ID: 34611793
[TBL] [Abstract][Full Text] [Related]
30. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
31. Inconsistencies in TTO and VAS values for EQ-5D health states.
Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
[TBL] [Abstract][Full Text] [Related]
32. [General population time trade-off values for 42 EQ-5D health states in South Korea].
Jo MW; Lee SI
J Prev Med Public Health; 2007 Mar; 40(2):169-76. PubMed ID: 17426430
[TBL] [Abstract][Full Text] [Related]
33. Italian population-based values of EQ-5D health states.
Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
[TBL] [Abstract][Full Text] [Related]
34. Estimating an EQ-5D-5L Value Set for China.
Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
[TBL] [Abstract][Full Text] [Related]
35. Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease.
Gandhi M; Tan RS; Lim SL; Rand K; Lam CSP; Luo N; Cheung YB
Value Health; 2022 Mar; 25(3):451-460. PubMed ID: 35227458
[TBL] [Abstract][Full Text] [Related]
36. Capturing Valuation Study Sampling Uncertainty in the Estimation of Health State Utility Values Using the EQ-5D-3L.
Poulimenos S; Round J; Baio G
Med Decis Making; 2024 May; 44(4):393-404. PubMed ID: 38584481
[TBL] [Abstract][Full Text] [Related]
37. Societal Preferences for EQ-5D Health States from a Brazilian Population Survey.
Viegas Andrade M; Noronha K; Kind P; Maia AC; Miranda de Menezes R; De Barros Reis C; Nepomuceno Souza M; Martins D; Gomes L; Nichele D; Calazans J; Mascarenhas T; Carvalho L; Lins C
Value Health Reg Issues; 2013 Dec; 2(3):405-412. PubMed ID: 29702778
[TBL] [Abstract][Full Text] [Related]
38. Valuing EQ-5D using time trade-off in France.
Chevalier J; de Pouvourville G
Eur J Health Econ; 2013 Feb; 14(1):57-66. PubMed ID: 21935715
[TBL] [Abstract][Full Text] [Related]
39. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
40. Rural population's preferences matter: a value set for the EQ-5D-3L health states for China's rural population.
Liu GG; Guan H; Jin X; Zhang H; Vortherms SA; Wu H
Health Qual Life Outcomes; 2022 Jan; 20(1):14. PubMed ID: 35093084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
